Tiny study explores simple skin cleanse to stop staph spread to babies
NCT ID NCT06541145
First seen Nov 16, 2025 · Last updated Jun 19, 2026 · Updated 24 times
Summary
This study looked at whether a 5-day skin treatment (mupirocin ointment in the nose and chlorhexidine baths) can reduce the amount of Staph aureus bacteria on mothers and their newborns. Only one mother participated, and researchers measured bacterial levels and surveyed her interest and compliance. The goal was to understand if such a treatment could limit bacteria spread between mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL COLONIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University
Durham, North Carolina, 27703, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mupirocin ointment and chlorhexidine cloths
What this could lead to
If successful, this could point toward a simple way to reduce Staph aureus transmission from mothers to newborns.
What could go wrong
This is a very small, completed study with only one participant, so results may not apply to others. It focuses on measurement, not treatment.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.